Loading…
Dmed, a bio-convergence medical device company, has secured automated production facilities capable of producing up to 3 million syringe-type medical devices per month at its Dmed Innovation Tower in Seongnam, South Korea. The company has started mass production of about 40 types of medical devices and plans total investment of 82 billion won by 2029.
| Site | Largest | Latest |
|---|---|---|
| Seongnam, South Korea | $60.0M | 2026-11-06 |